Daraxonrasib Approval for Pancreatic Cancer
Daraxonrasib Approval brings a new FDA-approved treatment option for adults with metastatic pancreatic cancer.
RK-251 Cancer Drug Shows Promise
RK-251 Cancer Drug is a new ROS-activated compound from Indian researchers showing promise in early cancer studies.